Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Continue

Publications

Resistance to apoptosis underpins corticosteroid-insensitivity of group 2 innate lymphoid cells.

Luo J. et al, (2019), J Allergy Clin Immunol

Correction: Synergistic activation of pro-inflammatory type-2 CD8 + T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering B. et al, (2019), Mucosal Immunology, 12, 581 - 581

FEVIPIPRANT INHIBITS PROSTAGLANDIN D2 MEDIATED ACTIVATION OF GROUP 2 INNATE LYMPHOID CELLS (ILC2S)

Sandham D. et al, (2019), RESPIROLOGY, 24, 105 - 105

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function.

Hardman C. et al, (2019), J Allergy Clin Immunol

Fevipiprant, a Selective Prostaglandin D(2)Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Tc2 cells (type-2 CD8(+)lymphocytes)

Xue L. et al, (2019), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 199

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)

Chen W. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Type-2 CD8+T lymphocytes responsive to PGD2/LTE4 in severe eosinophilic asthma

Hinks T. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52

Synergistic activation of pro-inflammatory type-2 CD8+ T lymphocytes by lipid mediators in severe eosinophilic asthma

Hilvering B. et al, (2018), Mucosal Immunology, 11, 1408 - 1419

Effects of Steroids in Cultured Human Type-2 Cytokine Producing Cells

Luo J. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197

Fevipiprant, a Selective Prostaglandin D-2 Receptor 2 Antagonist, Potently Inhibits Chemotaxis and Cytokine Production by Group 2 Innate Lymphoid Cells

Xue L. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197

The Effect of Oral Corticosteroids on Circulating Type-2 Cytokine Producing Cells in Patients with Severe Eosinophilic Asthma

Hynes G. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197

Cytometric Gating Stringency Impacts Studies of Type 2 Innate Lymphoid Cells in Asthma.

Hinks TSC. et al, (2017), Am J Respir Cell Mol Biol, 57, 745 - 747

Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines.

Salimi M. et al, (2017), J Allergy Clin Immunol, 140, 1090 - 1100.e11

Diagnosing eosinophilic asthma using a multivariate prediction model based on blood granulocyte responsiveness.

Hilvering B. et al, (2017), Allergy, 72, 1202 - 1211

Novel data analysis method for multicolour flow cytometry links variability of multiple markers on single cells to a clinical phenotype.

Tinnevelt GH. et al, (2017), Sci Rep, 7

Interaction Of Type 2 Cytotoxic T Lymphocytes And Mast Cell Lipid Mediators Contributes To Pathogenesis Of Eosinophilic Asthma

Xue L. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195

Sputum Il-17a Levels Correlate With Biomarkers Of Non-Eosinophilic Inflammation In Patients With Asthma

Hynes G. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195

Type 2 Cytotoxic T Lymphocytes In Patients With Severe Eosinophilic Asthma

Xue L. et al, (2017), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 195

SPUTUM CYTOKINES AND CLINICAL BIOMARKERS IN SEVERE ASTHMA

Shrimanker R. et al, (2016), THORAX, 71, A214 - A214

Psoriatic T cells recognize neolipid antigens generated by mast cell phospholipase delivered by exosomes and presented by CD1a.

Cheung KL. et al, (2016), J Exp Med, 213, 2399 - 2412

Load More

Include forthcoming?